DE69002328D1 - Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel. - Google Patents

Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.

Info

Publication number
DE69002328D1
DE69002328D1 DE9090905160T DE69002328T DE69002328D1 DE 69002328 D1 DE69002328 D1 DE 69002328D1 DE 9090905160 T DE9090905160 T DE 9090905160T DE 69002328 T DE69002328 T DE 69002328T DE 69002328 D1 DE69002328 D1 DE 69002328D1
Authority
DE
Germany
Prior art keywords
derivatives
bisphosphonic acids
arthritic agents
geminal bisphosphonic
geminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090905160T
Other languages
English (en)
Other versions
DE69002328T2 (de
Inventor
Colin Dunn
Richard Nugent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE69002328D1 publication Critical patent/DE69002328D1/de
Application granted granted Critical
Publication of DE69002328T2 publication Critical patent/DE69002328T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/65031Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE90905160T 1989-04-03 1990-03-08 Geminale bisphosphonsäuren und deren derivate als antiarthritische mittel. Expired - Fee Related DE69002328T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33261889A 1989-04-03 1989-04-03

Publications (2)

Publication Number Publication Date
DE69002328D1 true DE69002328D1 (de) 1993-08-26
DE69002328T2 DE69002328T2 (de) 1993-12-09

Family

ID=23299047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90905160T Expired - Fee Related DE69002328T2 (de) 1989-04-03 1990-03-08 Geminale bisphosphonsäuren und deren derivate als antiarthritische mittel.

Country Status (10)

Country Link
EP (1) EP0466730B1 (de)
JP (1) JPH04505011A (de)
KR (1) KR920701216A (de)
AT (1) ATE91689T1 (de)
AU (1) AU628158B2 (de)
CA (1) CA2046905A1 (de)
DE (1) DE69002328T2 (de)
DK (1) DK0466730T3 (de)
HU (1) HU207095B (de)
WO (1) WO1990012017A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2072015T3 (es) * 1990-08-21 1995-07-01 Upjohn Co Derivados del acido bisfosfonico como agente anti-artritico.
NZ253541A (en) * 1992-05-29 1997-01-29 Procter & Gamble Pharma Cyclic quaternary-n-containing phosphonate derivatives and medicaments
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
CA2188066C (en) * 1992-05-29 2000-12-05 Susan Mary Kaas Thio-substituted phosphonate compounds
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
PL175046B1 (pl) * 1992-05-29 1998-10-30 Procter & Gamble Pharma Nowe tio-podstawione, zawierające azot heterocykliczne związki fosfonianowe
AU4387893A (en) * 1992-07-16 1994-02-14 Upjohn Company, The Phosphono derivatives as antiinflammatory and antiarthritic agents
AU4848193A (en) * 1992-09-23 1994-04-26 Upjohn Company, The Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687768A (en) * 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
HU199151B (en) * 1987-03-10 1990-01-29 Yamanouchi Pharma Co Ltd Process for producing bis-phosphonic acid derivatives
DE3719513A1 (de) * 1987-06-11 1988-12-22 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DK0466730T3 (da) 1993-10-18
AU628158B2 (en) 1992-09-10
KR920701216A (ko) 1992-08-11
EP0466730B1 (de) 1993-07-21
AU5330690A (en) 1990-11-05
CA2046905A1 (en) 1990-10-04
ATE91689T1 (de) 1993-08-15
DE69002328T2 (de) 1993-12-09
WO1990012017A1 (en) 1990-10-18
EP0466730A1 (de) 1992-01-22
HU207095B (en) 1993-03-01
HUT58751A (en) 1992-03-30
HU902754D0 (en) 1991-12-30
JPH04505011A (ja) 1992-09-03

Similar Documents

Publication Publication Date Title
DE69128362T2 (de) Zusammensetzungen und verfahren zur identifizierung von molekülen mit biologischer wirksamkeit
FI960851A (fi) Menetelmä N-amino-1-hydroksi-alkylideeni-1,1-bisfosfonihappojen valmistamiseksi
DE69026696D1 (de) Vorrichtung zur kohärenten Addition von Laserstrahlen
YU51694A (sh) Postupak za dobijanje n-amino-1-hidroksi-alkilden-1,1-bifosfinskih kiselina
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
IT9022132A0 (it) Sistema modulare per la realizzazione di pareti attrezzate e banchi dilavoro in particolare per laboratori
DE68908878D1 (de) Vielseitige funktionelle vorrichtung zum reinigen im abstand und behandeln von flächen und gegenständen entlang den strassenrändern.
DE3481997D1 (de) Verfahren zur herstellung optisch aktiver aryloxypropionsaeuren und deren als herbizide verwendbare derivate.
DE69002328D1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
ATE99118T1 (de) Biozide mittel und behandlungsverfahren.
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
ES2114855T3 (es) Procedimiento para la preparacion de 2-acilamino-6-halogeno-purina a partir de 2,9-diacilguanina.
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
BR9007019A (pt) Aplicacao de esteres polioxialquilicos de acidos monocarboxilicos como agentes de tratamento de texteis pouco espumantes
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
GR3005231T3 (de)
DE58907569D1 (de) Isomere Trimethylbicyclo[4.3.0]nonan-Derivate.
IT1208760B (it) Trattamento delle malattie infiammatorie articolari
ES2011472B3 (es) Procedimiento para el tratamiento de soluciones acuosas producidas en la carboxilacion de compuestos olefinicos no saturados.
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee